Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sen Zhuang"'
Publikováno v:
Plant Production Science, Vol 12, Iss 1, Pp 100-108 (2009)
Excessive nitrogen fertilization results in low nitrogen-use efficiency. To improve nitrogen management for high yield and high nitrogen efficiency in rice and wheat, we developed a knowledge-based nitrogen fertilization model by integrating the quan
Externí odkaz:
https://doaj.org/article/9b55e9be23aa46899bbda567457cb210
Publikováno v:
In Journal of Building Engineering 1 May 2024 84
Publikováno v:
In Construction and Building Materials 18 April 2022 328
Autor:
Tito Fojo, Susan Bates, Lyn Mickley Huff, Marianne Poruchynsky, Herb Kotz, Sen Zhuang, Maureen Edgerly, Michael Menefee, Hui Huang
Supplementary Data from A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23774ca0b7b133a4eb20b0739e3cc64e
https://doi.org/10.1158/1078-0432.22439845.v1
https://doi.org/10.1158/1078-0432.22439845.v1
Autor:
Tito Fojo, Susan Bates, Lyn Mickley Huff, Marianne Poruchynsky, Herb Kotz, Sen Zhuang, Maureen Edgerly, Michael Menefee, Hui Huang
Purpose: Ixabepilone (Ixempra; BMS-247550) is an epothilone B analog and nontaxane microtubule-stabilizing compound with clinical activity in a range of solid tumors. This phase II study was conducted to assess the efficacy and safety of ixabepilone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a70e23c3be2d95736507e6afe3db9bf
https://doi.org/10.1158/1078-0432.c.6517249.v1
https://doi.org/10.1158/1078-0432.c.6517249.v1
Publikováno v:
Chinese Journal of Liquid Crystal and Displays. 36:761-771
Autor:
Yee Tak Derek Cheung, Yuan Jiang, Hui Li, Chiang Ye, Lie Yang, Jun Sheng Sun, Tai Hing Lam, Na Li, Yan Yang, Xiu Yan Ou, Jiu Chang Wu, Sai Yin Ho, Ho Cheung William Li, Jian Zhou, Jin Hong Lu, Liu Qing Liu, Zhuang Hong Huang, Jing Ying Chen, Peiru Lin, Yao He, Wei Hua Zhu, Wen Hui Gao, Run Sen Zhuang, Gang Zhou, Sheng Hua Su, Nan Jiang, Jun Feng Wang, Kar Keung Cheng, Yi Sheng Lai, Chao Qiang Jiang
Publikováno v:
Addiction (Abingdon, England)
Background and aims Three to 10 minutes of smoking cessation advice by physicians is effective to increase quit rates, but is not routinely practised. We examined the effectiveness of physicians' very brief (approximately 30 sec) smoking cessation in
Autor:
Bertrand Arnulf, Lotfi Benboubker, Claire Mathiot, Jérôme J. Lambert, Cécile Sonntag, Pieter Sonneveld, Lixia Pei, Aurore Perrot, Jean Paul Fermand, Karim Belhadj, Pascal Lenain, Matthijs Westerman, Saskia K. Klein, Carla de Boer, William Deraedt, Soraya Wuilleme, Anne-Marie Stoppa, Jessica Vermeulen, Frédérique Orsini-Piocelle, Brigitte Kolb, Jordan M. Schecter, Jean-Pierre Marolleau, Cyrille Hulin, Mark-David Levin, Tobias Kampfenkel, Sen Zhuang, Jill Corre, Christopher Chiu, Jean Fontan, Hervé Avet-Loiseau, Thomas Dejoie, Martine Escoffre-Barbe, Murielle Roussel, Michel Delforge, Jean-Richard Eveillard, Cyrille Touzeau, Lionel Karlin, Tahamtan Ahmadi, Philippe Moreau, Niels W.C.J. van de Donk, Marie C. Béné, Marie-Christiane Vekemans, Sonja Zweegman, Xavier Leleu, Reda Garidi, Hélène Caillon, Mourad Tiab, Margaret Macro, Nathalie Meuleman, Elena Smith, Laurent Garderet, Kon-Siong Jie, Thierry Facon, Denis Caillot, Frédérique Kuhnowski, Annemiek Broijl, Michel Attal, Chantal Doyen
Publikováno v:
The Lancet
The Lancet, 2019, 394 (10192), pp.29-38. ⟨10.1016/S0140-6736(19)31240-1⟩
Moreau, P, Attal, M, Hulin, C, Arnulf, B, Belhadj, K, Benboubker, L, Béné, M C, Broijl, A, Caillon, H L, Caillot, D, Corre, J, Delforge, M, Dejoie, T, Doyen, C, Facon, T, Sonntag, C C, Fontan, J, Garderet, L, Jie, K-S, Karlin, L, Kuhnowski, F, Lambert, J R, Leleu, X, Lenain, P, Macro, M, Mathiot, C, Orsini-Piocelle, F, Perrot, A, Stoppa, A-M, van de Donk, N W CJ, Wuilleme, S, Zweegman, S, Kolb, B, Touzeau, C, Roussel, M, Tiab, M, Marolleau, J-P, Meuleman, N, Vekemans, M-C, Westerman, M, Klein, S K, Levin, M-D, Fermand, J P, Escoffre-Barbe, M, Eveillard, J-R, Garidi, R, Ahmadi, T, Zhuang, S, Chiu, C, Pei, L, de Boer, C, Smith, E, Deraedt, W, Kampfenkel, T, Schecter, J, Vermeulen, J, Avet-Loiseau, H & Sonneveld, P 2019, ' Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study ', The Lancet, vol. 394, no. 10192, pp. 29-38 . https://doi.org/10.1016/S0140-6736(19)31240-1
The Lancet, 394(10192), 29-38. Elsevier Limited
Lancet, Vol. 394, no. 10192, p. 29-38 (2019)
Lancet (UK), 394(10192), 29-38. Elsevier Ltd.
The Lancet, 2019, 394 (10192), pp.29-38. ⟨10.1016/S0140-6736(19)31240-1⟩
Moreau, P, Attal, M, Hulin, C, Arnulf, B, Belhadj, K, Benboubker, L, Béné, M C, Broijl, A, Caillon, H L, Caillot, D, Corre, J, Delforge, M, Dejoie, T, Doyen, C, Facon, T, Sonntag, C C, Fontan, J, Garderet, L, Jie, K-S, Karlin, L, Kuhnowski, F, Lambert, J R, Leleu, X, Lenain, P, Macro, M, Mathiot, C, Orsini-Piocelle, F, Perrot, A, Stoppa, A-M, van de Donk, N W CJ, Wuilleme, S, Zweegman, S, Kolb, B, Touzeau, C, Roussel, M, Tiab, M, Marolleau, J-P, Meuleman, N, Vekemans, M-C, Westerman, M, Klein, S K, Levin, M-D, Fermand, J P, Escoffre-Barbe, M, Eveillard, J-R, Garidi, R, Ahmadi, T, Zhuang, S, Chiu, C, Pei, L, de Boer, C, Smith, E, Deraedt, W, Kampfenkel, T, Schecter, J, Vermeulen, J, Avet-Loiseau, H & Sonneveld, P 2019, ' Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study ', The Lancet, vol. 394, no. 10192, pp. 29-38 . https://doi.org/10.1016/S0140-6736(19)31240-1
The Lancet, 394(10192), 29-38. Elsevier Limited
Lancet, Vol. 394, no. 10192, p. 29-38 (2019)
Lancet (UK), 394(10192), 29-38. Elsevier Ltd.
Background: Bortezomib, thalidomide, and dexamethasone (VTd) plus autologous stem-cell transplantation is standard treatment in Europe for transplant-eligible patients with newly diagnosed multiple myeloma. We evaluated whether the addition of daratu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbfa6c08ba25919f03b6f545d38d13cf
https://hal-u-picardie.archives-ouvertes.fr/hal-03605015
https://hal-u-picardie.archives-ouvertes.fr/hal-03605015
Autor:
Indrajeet Singh, Alicia J. Allred, Sen Zhuang, Jordan M. Schecter, Enrique Zudaire, Jesus G. Berdeja, Syed Rizvi, Arnob Banerjee, Jenna D. Goldberg, Tzu-Min Yeh, Andrzej Jakubowiak, Deepu Madduri, Jeffrey R. Infante, Xiaohu (Frank) Fan, Saad Z. Usmani, Sundar Jagannath
Publikováno v:
Blood. 134:577-577
JNJ-68284528 (JNJ-4528) is a chimeric antigen receptor T cell (CAR-T) therapy containing two BCMA-targeting single-domain antibodies designed to confer avidity. A first-in-human phase 1 study (LEGEND-2) conducted in China of LCAR-B38M, an identical C
Publikováno v:
Journal of Materials in Civil Engineering. 29
To investigate the cracking of concrete in reinforced concrete circular pipe culverts, which are mostly manufactured by a process of centrifugal roller suspension, buried more than 5,000 mm...